Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 62 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 7101557

    Combined tissue factor methods for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Sep 5, 2006 · Expires Aug 31, 2026

    granted
  2. US 7094873

    Polypeptide that interacts with heat shock proteins

    The Board of Regents of the University of Texas System · Granted Aug 22, 2006 · Expires Aug 17, 2026

    granted
  3. US 7094758

    Apoptotic compounds

    The Board of Regents of the University of Texas System · Granted Aug 22, 2006 · Expires Aug 17, 2026

    granted
  4. US 7078182

    TAO protein kinase polypeptides and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Jul 18, 2006 · Expires Jul 13, 2026

    granted
  5. US 7070957

    STARS—a muscle-specific actin-binding protein

    The Board of Regents of the University of Texas System · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  6. US 7071318

    Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells

    The Board of Regents of the University of Texas System · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  7. US 7067633

    Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in human cells

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  8. US 7067256

    Ribozyme mediated inactivation of the androgen receptor

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  9. US 7067109

    Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  10. US 7067111

    Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  11. US 7067254

    Diagnosis and treatment of inflammation and hyperactive immune conditions

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  12. US 7060689

    Methods and compositions for delivery and retention of active agents to lymph nodes

    The Board of Regents of the University of Texas System · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  13. US 7056509

    Antibody methods for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  14. US 7041784

    Apoptotic compounds

    The Board of Regents of the University of Texas System · Granted May 9, 2006 · Expires May 4, 2026

    expired
  15. US 7037583

    Functionalized zirconium oxide particles

    The Board of Regents of the University of Texas System · Granted May 2, 2006 · Expires Apr 27, 2026

    expired
  16. US 7033750

    Recombinant P53 adenovirus methods and compositions

    The Board of Regents of the University of Texas System · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  17. US 7029696

    Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II) complexes

    The Board of Regents of the University of Texas System · Granted Apr 18, 2006 · Expires Apr 13, 2026

    expired
  18. US 7022720

    Synthetic diazonamides as novel anti-mitotic agents

    The Board of Regents of the University of Texas System · Granted Apr 4, 2006 · Expires Mar 30, 2026

    expired
  19. US 7022484

    Methods for treating neuropathological states and neurogenic inflammatory states and methods for identifying compounds useful therein

    The Board of Regents of the University of Texas System · Granted Apr 4, 2006 · Expires Mar 30, 2026

    expired
  20. US 7008633

    Local regional chemotherapy and radiotherapy using in situ hydrogel

    The Board of Regents of the University of Texas System · Granted Mar 7, 2006 · Expires Mar 2, 2026

    expired
  21. US 7005424

    Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy

    The Board of Regents of the University of Texas System · Granted Feb 28, 2006 · Expires Feb 23, 2026

    expired
  22. US 7005512

    Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells

    The Board of Regents of the University of Texas System · Granted Feb 28, 2006 · Expires Feb 23, 2026

    expired
  23. US 6998117

    Cancer treatment with retroviral vectors comprising wild-type p53

    The Board of Regents of the University of Texas System · Granted Feb 14, 2006 · Expires Feb 9, 2026

    expired
  24. US 6995188

    S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer

    The Board of Regents of the University of Texas System · Granted Feb 7, 2006 · Expires Feb 2, 2026

    expired